Ann Surg Treat Res.
2024 Jun;106(6):370-370. 10.4174/astr.2024.106.6.370.
CORRIGENDUM: Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
- Affiliations
-
- 1Department of Surgery, Hanyang University College of Medicine, Seoul, Korea
- 2Research Institute of Regenerative Medicine and Stem Cells, Hanyang University, Seoul, Korea
- 3Major in Medical Genetics, Department of Medicine, Graduate School, Hanyang University, Seoul, Korea
- 4Department of Genetics, Hanyang University College of Medicine, Seoul, Korea
- 5Department of Biomedical Science, Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea
- KMID: 2556330
- DOI: http://doi.org/10.4174/astr.2024.106.6.370
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Epigenetic modulation inhibits epithelial-mesenchymal transition-driven fibrogenesis and enhances characteristics of chemically-derived hepatic progenitors
- Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
- The efficacy of exosomes from human chemically derived hepatic progenitors in liver damage alleviation: a preclinical experimental study
- Consideration of EphA2 in relation to epithelial-mesenchymal transition in uterine endometrial cancer
- The Role of Epithelial-mesenchymal Transition in the Gastroenterology
